Dr. Mark Hatley is the Director of the Molecular Oncology Division of the Department of Oncology at St. Jude Children’s Research Hospital. His lab’s research focuses on the developmental and genetic mechanisms behind a cellular transformation in pediatric rhabdomyosarcoma. They are working to understand the process of cancer transformation, and how cell of origin dictates features of the disease.